Lieuwe de Haan, MD, PhD

  • 7Articles
  • 28.9KReads
  • 1999–2024Active
  • 44Collaborators
  • 164Citations

About

Lieuwe de Haan, MD, PhD, is affiliated with the Department of Psychiatry at Amsterdam UMC Location AMC in Amsterdam, the Netherlands. With publications spanning from 1999 to 2024, de Haan has contributed extensively to the study of schizophrenia and schizoaffective disorders, focusing on cognitive changes, obsessive-compulsive symptoms, and self-disturbance in these populations. The work also explores pharmacological effects of antipsychotics such as haloperidol, risperidone, olanzapine, and clozapine, as well as early cardiovascular risk factors in recent-onset psychosis. De Haan frequently collaborates with researchers including Arjen L. Sutterland and Cornelis L. Mulder.

Publications

JCP
Changes in Cognition in Patients With Schizophrenia
Meta-Analysis

Changes in Cognition in Patients With Schizophrenia

September 25, 2024

Only marginal improvements in cognition were seen over time; the greatest were achieved for patients with an illness duration shorter than 10 years.
, , , et al
JCP
Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
Original Research

Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

September 28, 2022

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500 patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
, , , et al
JCP
Original Research

Advanced Glycation End Products in Early Psychosis

April 25, 2017

While cardiovascular disease management has progressed significantly in the general population, the same is not true for patients with severe mental illness. Read this study to explore ways to...
, , , et al
PCC
Article

Self-Disturbance in Schizophrenia: A Phenomenological Approach to Better Understand Our Patients

January 17, 2013

A phenomenological approach explains the apparently unintelligible experiences of patients with schizophrenia as a disruption of the normal self-perception. Patients with schizophrenia suffer from a decline of "me," the...
, , , et al
JCP
Original Research

Emotional Experience and Estimates of D2 Receptor Occupancy in Psychotic Patients Treated With Haloperidol, Risperidone, or Olanzapine: An Experience Sampling Study

December 14, 2010

, , , et al
JCP
Original Research

Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders

February 1, 2002

, , , et al
JCP
Original Research

Clozapine and Obsessions in Patients With Recent-Onset Schizophrenia and Other Psychotic Disorders.

June 30, 1999

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe